Skip to content
10-Q

Quarterly Report

KODIAK SCIENCES INC. KOD

0001193125-26-211951

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 62.58M sh
Shares Diluted Q1 2026 · Mar 31, 2026 61.86M sh
Shares Diluted Q1 2026 · Mar 31, 2025 52.75M sh
Capex Q1 2026 · Mar 31, 2026 $942K
Capex Q1 2026 · Mar 31, 2025 $270K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$40.01M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$29.08M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $169.53M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $209.86M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $138.85M
Stockholders Equity Q1 2026 · Mar 31, 2026 $112.1M
Stockholders Equity Q1 2026 · Dec 31, 2025 $157.38M
Stockholders Equity Q1 2026 · Mar 31, 2025 $108.84M
Stockholders Equity Q1 2026 · Dec 31, 2024 $150.29M
Current Liabilities Q1 2026 · Mar 31, 2026 $49.57M
Current Liabilities Q1 2026 · Dec 31, 2025 $45.53M
Total Liabilities Q1 2026 · Mar 31, 2026 $193.91M
Total Liabilities Q1 2026 · Dec 31, 2025 $194.15M
Current Assets Q1 2026 · Mar 31, 2026 $175.26M
Current Assets Q1 2026 · Dec 31, 2025 $214.82M
Total Assets Q1 2026 · Mar 31, 2026 $306.01M
Total Assets Q1 2026 · Dec 31, 2025 $351.53M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.94
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.09
Eps Basic Q1 2026 · Mar 31, 2026 −$0.94
Eps Basic Q1 2026 · Mar 31, 2025 −$1.09
Sga Expense Q1 2026 · Mar 31, 2026 $11.23M
Sga Expense Q1 2026 · Mar 31, 2025 $15.43M
Rd Expense Q1 2026 · Mar 31, 2026 $48.55M
Rd Expense Q1 2026 · Mar 31, 2025 $43.64M
Net Income Q1 2026 · Mar 31, 2026 −$58.16M
Net Income Q1 2026 · Mar 31, 2025 −$57.46M
Operating Income Q1 2026 · Mar 31, 2026 −$59.78M
Operating Income Q1 2026 · Mar 31, 2025 −$59.07M